Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients

NCT06557421 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT06557421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
Lead sponsor
Institut Paoli-Calmettes
Phase
Phase 2
Overall status
Recruiting
Start date
February 4, 2026
Completion date
November 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia